Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer
Qiwei Wang, Johann S. Bergholz, Liya Ding, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Therapeutic targeting of tumour myeloid cells
Simon T. Barry, Dmitry I. Gabrilovich, Owen J. Sansom, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 216-237
Closed Access | Times Cited: 147
A protein-based cGAS-STING nanoagonist enhances T cell-mediated anti-tumor immune responses
Xuan Wang, Yingqi Liu, Chencheng Xue, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 138
Clinical and translational advances in ovarian cancer therapy
Panagiotis A. Konstantinopoulos, Ursula A. Matulonis
Nature Cancer (2023) Vol. 4, Iss. 9, pp. 1239-1257
Closed Access | Times Cited: 116
Radiation-induced tumor immune microenvironments and potential targets for combination therapy
Siyu Guo, Yihan Yao, Yang Tang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 59
Immunogenic PANoptosis‐Initiated Cancer Sono‐Immune Reediting Nanotherapy by Iteratively Boosting Cancer Immunity Cycle
Liqiang Zhou, Jinxiao Lyu, Fang Liu, et al.
Advanced Materials (2023) Vol. 36, Iss. 2
Closed Access | Times Cited: 56
The DNA Damage Response and Inflammation in Cancer
Vanessa Klapp, Beatriz Álvarez-Abril, Giuseppe Leuzzi, et al.
Cancer Discovery (2023) Vol. 13, Iss. 7, pp. 1521-1545
Open Access | Times Cited: 54
PI3Kβ controls immune evasion in PTEN-deficient breast tumours
Johann S. Bergholz, Qiwei Wang, Qi Wang, et al.
Nature (2023) Vol. 617, Iss. 7959, pp. 139-146
Closed Access | Times Cited: 52
Harnessing innate immune pathways for therapeutic advancement in cancer
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 51
STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer
Liya Ding, Qiwei Wang, Antons Martincuks, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 1, pp. e005627-e005627
Open Access | Times Cited: 50
Medicinal plant-derived mtDNA via nanovesicles induces the cGAS-STING pathway to remold tumor-associated macrophages for tumor regression
Jinfeng Liu, Jiaxin Xiang, Cuiyuan Jin, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 48
The balance of STING signaling orchestrates immunity in cancer
Klara Rasmussen Bollerup Lanng, Emil Leth Lauridsen, Martin R. Jakobsen
Nature Immunology (2024) Vol. 25, Iss. 7, pp. 1144-1157
Closed Access | Times Cited: 36
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Xi Chen, Zhijie Xu, Tongfei Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 21
A temporal perspective for tumor-associated macrophage identities and functions
Camille Blériot, Garett Dunsmore, Direna Alonso‐Curbelo, et al.
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 747-758
Closed Access | Times Cited: 21
Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy
Hao Yang, Zhong-Hao Ji, Hengzong Zhou, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 30
Manganese-Enriched Zinc Peroxide Functional Nanoparticles for Potentiating Cancer Immunotherapy
Mengli Zhou, Shuang Liang, Dan Liu, et al.
Nano Letters (2023) Vol. 23, Iss. 22, pp. 10350-10359
Closed Access | Times Cited: 30
Understanding nucleic acid sensing and its therapeutic applications
Ling-Zu Kong, Seok‐min Kim, Chunli Wang, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 11, pp. 2320-2331
Open Access | Times Cited: 29
Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control
Kyle Concannon, Benjamin B. Morris, Carl M. Gay, et al.
Molecular Cell (2023) Vol. 83, Iss. 5, pp. 660-680
Open Access | Times Cited: 27
POLQ inhibition elicits an immune response in homologous recombination–deficient pancreatic adenocarcinoma via cGAS/STING signaling
Grace E. Oh, Annie Wang, Lidong Wang, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 11
Open Access | Times Cited: 27
Mechanism of PARP inhibitor resistance and potential overcoming strategies
Xiaoyu Fu, Ping Li, Qi Zhou, et al.
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 306-320
Open Access | Times Cited: 26
Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity
Wenqun Zhong, Youtao Lu, Xuexiang Han, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113224-113224
Open Access | Times Cited: 25
Targeting tumor-associated macrophages with STING agonism improves the antitumor efficacy of osimertinib in a mouse model of EGFR-mutant lung cancer
Ziying Lin, Qiwei Wang, Tao Jiang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
The cGAS-STING pathway: a therapeutic target in diabetes and its complications
Wenjie He, Xingrui Mu, Xingqian Wu, et al.
Burns & Trauma (2024) Vol. 12
Open Access | Times Cited: 13
Hypoxic glioblastoma-cell-derived extracellular vesicles impair cGAS-STING activity in macrophages
Stoyan Tankov, Marija Petrovic, Marc Lecoultre, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 13
STING agonist-based hydrogel enhances immune activation in synergy with radiofrequency ablation for hepatocellular carcinoma treatment
Feng Ao, Xi Li, Yan Zhi Tan, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 296-308
Closed Access | Times Cited: 13
Tumor Microenvironment-Activatable Nanosystem Capable of Overcoming Multiple Therapeutic Obstacles for Augmenting Immuno/Metal-Ion Therapy
Qian Cheng, Xiao‐Lei Shi, Yu‐Zhe Chen, et al.
ACS Nano (2024) Vol. 18, Iss. 12, pp. 8996-9010
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top